Novosteo

Novosteo

Founded to reduce the morbidity, mortality and loss of productivity associated with bone fractures.

Launch date
Employees
Market cap
-
Enterprise valuation
$22—33m (Dealroom.co estimates Feb 2021.)
West Lafayette Indiana (HQ)
  • Edit
DateInvestorsAmountRound

$1.7m

Grant

$500k

Seed

$5.5m

Series A
*

N/A

Acquisition
Total Funding$7.7m

Recent News about Novosteo

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.